Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet. 2021;398(10300):622–37.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–33.

Google Scholar 

Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. 1998;338(6):347–54.

PubMed  Article  CAS  Google Scholar 

Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800.

PubMed  Article  CAS  Google Scholar 

Maca J, Jor O, Holub M, et al. Past and present ARDS mortality rates: a systematic review. Respir Care. 2017;62(1):113–22.

PubMed  Article  Google Scholar 

Pham T, Rubenfeld GD. Fifty years of research in ARDS. The epidemiology of acute respiratory distress syndrome. A 50th birthday review. Am J Respir Crit Care Med. 2017;195(7):860–70.

PubMed  Article  Google Scholar 

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Tang X, Du RH, Wang R, et al. Comparison of hospitalized patients with ARDS caused by COVID-19 and H1N1. Chest. 2020;158(1):195–205.

PubMed  Article  CAS  Google Scholar 

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Cao B, Li XW, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361(26):2507–17.

PubMed  Article  CAS  Google Scholar 

Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–34.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N Engl J Med. 2020;383(2):120–8.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181(1):72–9.

PubMed  Article  Google Scholar 

Gupta E, Jacobs MD, George G, Roman J. Beyond the ICU: Frailty and post-ICU disability. Healthcare use after acute respiratory distress syndrome and severe sepsis. Am J Respir Crit Care Med. 2019;199(8):1028–30.

PubMed  Article  Google Scholar 

Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–15.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Morrison TJ, Jackson MV, Cunningham EK, et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med. 2017;196(10):1275–86.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. In: Abbas AK, Galli SJ, Howley PM editors Annual Review of Pathology: Mechanisms of Disease. Vol 6. 147–163 (2011).

Lemyze M, Mallat J, Thevenin D. Prone positioning in the acute respiratory distress syndrome. N Engl J Med. 2013;369(10):980.

PubMed  Google Scholar 

Curley GF, Laffey JG, Zhang H, Slutsky AS. Biotrauma and ventilator-induced lung injury: clinical implications. Chest. 2016;150(5):1109–17.

PubMed  Article  Google Scholar 

Albert RK, Smith B, Perlman CE, Schwartz DA. Is progression of pulmonary fibrosis due to ventilation-induced lung injury? Am J Respir Crit Care Med. 2019;200(2):140–51.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Tieu A, Hu K, Gnyra C, et al. Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: a meta-analysis. J Extracell Vesicles. 2021;10(12): e12141.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Monsel A, Zhu YG, Gennai S, Hao Q, Liu J, Lee JW. Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology. 2014;121(5):1099–121.

PubMed  Article  CAS  Google Scholar 

Abraham A, Krasnodembskaya A. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome. Stem Cells Transl Med. 2020;9(1):28–38.

PubMed  Article  CAS  Google Scholar 

Deng H, Wu L, Liu M, et al. Bone marrow mesenchymal stem cell-derived exosomes attenuate LPS-induced ARDS by modulating macrophage polarization through inhibiting glycolysis in macrophages. Shock. 2020;54(6):828–43.

PubMed  Article  CAS  Google Scholar 

Hao Q, Gudapati V, Monsel A, et al. Mesenchymal stem cell-derived extracellular vesicles decrease lung injury in mice. J Immunol. 2019;203(7):1961–72.

PubMed  Article  CAS  Google Scholar 

Zhang GY, Liao T, Zhou SB, Fu XB, Li QF. Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome. Lancet Respir Med. 2015;3(4):e11-12.

PubMed  Article  Google Scholar 

Carnino JM, Hao Kwok Z, Jin Y. Extracellular vesicles: a novel opportunity for precision medicine in respiratory diseases. Front Med Lausanne. 2021;8:661679.

PubMed  PubMed Central  Article  Google Scholar 

Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393–403.

PubMed  CAS  Google Scholar 

Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013;85(1):3–10.

PubMed  Article  Google Scholar 

Lopes-Pacheco M, Robba C, Rocco PRM, Pelosi P. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome. Cell Biol Toxicol. 2020;36(1):83–102.

PubMed  Article  Google Scholar 

Xiao K, He W, Guan W, et al. Mesenchymal stem cells reverse EMT process through blocking the activation of NF-kappaB and Hedgehog pathways in LPS-induced acute lung injury. Cell Death Dis. 2020;11(10):863.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Xu Y, Zhu J, Feng B, et al. Immunosuppressive effect of mesenchymal stem cells on lung and gut CD8(+) T cells in lipopolysaccharide-induced acute lung injury in mice. Cell Prolif. 2021;54(5): e13028.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Periera-Simon S, Xia X, Catanuto P, et al. Anti-fibrotic effects of different sources of MSC in bleomycin-induced lung fibrosis in C57BL6 male mice. Respirology. 2021;26(2):161–70.

PubMed  Article  Google Scholar 

Wang NF, Bai CX. Bone marrow-derived mesenchymal stem cells modulate autophagy in RAW264.7 macrophages via the phosphoinositide 3-kinase/protein kinase B/heme oxygenase-1 signaling pathway under oxygen-glucose deprivation/restoration conditions. Chin Med J (Engl). 2021;134(6):699–707.

Article  Google Scholar 

Huang T, Zhang T, Jiang X, et al. Iron oxide nanoparticles augment the intercellular mitochondrial transfer-mediated therapy. Sci Adv. 2021;7(40):eabj0534.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Ikonomou L, Wagner DE, Turner L, Weiss DJ. Translating basic research into safe and effective cell-based treatments for respiratory diseases. Ann Am Thorac Soc. 2019;16(6):657–68.

PubMed  Article  Google Scholar 

Matthay MA, Calfee CS, Zhuo H, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019;7(2):154–62.

PubMed  Article  Google Scholar 

Lanzoni G, Linetsky E, Correa D, et al. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1/2a, randomized controlled trial. Stem Cells Transl Med